System Transmission

Top Signal

100#1 JOB

Activity

2162Ripe

+918 today

System

Live3m

Terminal Asset View

stockNASDAQ

INAB

$1.89-1.05%

IN8bio Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

15Overripe

Live Analysis Active

Company Mission

IN8bio develops cancer treatments using genetically modified immune cells called gamma-delta T cells. These treatments are designed to help patients fight cancer more effectively by enhancing their own immune systems. The company earns money through research grants, partnerships with larger pharmaceutical companies, and potentially future product sales if their treatments receive approval.

INA

Industry Context

The biotechnology industry focuses on developing medical treatments using living cells and biological systems. Companies in this space often work on cutting-edge therapies for serious diseases like cancer, with many investing heavily in research and development before their treatments reach patients.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

68Matrix

Market Momentum

54.8— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.6x— Normal Volume

Today's Change

-1.05%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing INAB across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:50 PM UTC

As-of 03-14-2026 19:35 UTC

Develops cancer treatments using genetically modified immune cells and makes money by selling these therapies to hospitals and research centers.

Weekly price consolidation signals energy building for the next trend, suggesting potential breakout moves ahead.

Biotech sector showing increased interest in cell therapies, which could benefit companies developing innovative cancer treatments.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...